Jeanmarie Guenot – Chief Executive Officer of Amphivena Therapeutics Inc.

Jeanmarie Guenot is the current Chief Executive Officer and President of Amphivena Therapeutics Incorporation, a business specialized in developing advanced bifunctional antibody treatments aimed at curing hematologic malignancies. She has a remarkable interest and proficiency in building companies. Additionally, Jeanmarie Guenot has been employed in all sectors of industries including pharmaceutical research and development, economic and corporate evolution, both private and industry, project management, and venture capital. Also, she is a Ph.D. holder and has over twenty years of involvement in the biotechnology and pharmaceutical industry.

Anterior to her current work position, Dr. Jeanmarie Guenot built, founded, and manages SKS Ocular, a newly established ophthalmic company incubator. SKS Ocular focuses on ocular inflammation, macular degeneration, developing dry Advanced Micro Devices, and supporting delivery of treatments and technologies that use ocular drugs for treating glaucoma. Earlier, Jeanmarie Guenot worked in Shanghai and Basel for Hoffmann-La Roche as a business advisor. Besides, she also worked at PDL BioPharma as the Vice President of Business and Corporate Growth. As the Vice President, she performed several roles for PDL’s research and development such as taking the lead in mergers and acquisitions, licensing, alliance management and creating commercial product portfolios for the company.

Jeanmarie Guenot commenced her career as a business executive at Atlas Venture on amphivena.com. While in Atlanta Venture, she built companies focused on life-science, and directed venture capital investments for the enterprise. Dr. Guenot began her career as a leading scientist in Preclinical Research and Development at Hoffmann-La Roche. As a scientist, she discovered and developed drugs used to treat inflammation, metabolic diseases, oncology, and autoimmune diseases. Furthermore, Dr. Guenot practiced medicinal and physical chemistry. Here, she focused in drug design, NMR and X-ray refinement, and semi-empirical techniques and quantum mechanical for molecular dynamics on guenotllc.com. Jeanmarie Guenot earned her Master of Business Administration in 1999 from The Wharton School which is located inside the University of Pennsylvania. Moreover, she received her Ph.D. in 1987 from the University of California, based in San Francisco.

Read more: Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies

Leave a Reply

Your email address will not be published. Required fields are marked *